Paola Pacelli

4PUBLICATIONS
17CO-AUTHORS
Gene and molecular therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 26, 2026
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM.

Alessandro Gozzetti, Paola Pacelli, Federico Caroni

|May 07, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.

Anna Sicuranza, Massimo Breccia, Francesco Iuliano

|Feb 26, 2025
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies.

Federico Caroni, Vincenzo Sammartano, Paola Pacelli

|Aug 26, 2023
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).

Elisabetta Abruzzese, Monica Bocchia, Malgorzata Monika Trawinska

Pageof 1

Frequent Collaborators

4 joint publications

Anna Sicuranza

3 joint publications

Monica Bocchia

2 joint publications

Elisabetta Abruzzese

2 joint publications

Donatella Raspadori